Metastatic EML4-ALK fusion detected by circulating DNA genotyping in an EGFR-mutated NSCLC patient and successful management by adding ALK inhibitors: a case report

    BMC Cancer, pp. 62-62, 2016.

    Cited by: 0|Bibtex|Views1|
    Keywords:
    NSCLC EGFR mutation EML4-ALK rearrangement Co-existence

    Abstract:

    BackgroundRebiopsy is highly recommended to identify the mechanism of acquired resistance to EGFR-TKIs in advanced lung cancer. Recent advances in multiplex genotyping based on circulating tumor DNA (ctDNA) provide a strong and non-invasive alternative for detection of the resistance mechanism.

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments